Skip to main content

Want a detailed portfolio tracker?

Neuphoria Therapeutics (NEUP) Revenue (2023 - 2026)

Neuphoria Therapeutics (NEUP) revenue from Sep 30, 2023 to Mar 31, 2026. The TTM Neuphoria Therapeutics (NEUP) revenue is $0. You can adjust inflation or export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Annual Revenue

Quarterly Revenue

Annual Revenue change of Neuphoria Therapeutics (NEUP)

YearRevenueChange
2026$0-100.00%
2025$16MN/A
2024$0N/A
2023$0-100.00%
2022$260KN/A
2021$0-100.00%
2020$50KN/A